Vimarsana
Biggest News Aggregation in the World

Page 10 - Aser Surgery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aser Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aser Surgery Today - Breaking & Trending Today

Seven Trends to Watch in Healthtech AI - Vimarsana News

Seven Trends to Watch in Healthtech AI

As the role of AI in healthcare settings continues to evolve and generate debate, here are seven things to keep an eye on.

Viking Therapeutics Obesity Drug's Data Raise Best-in-Class Expectations - Vimarsana News

Viking Therapeutics Obesity Drug's Data Raise Best-in-Class Expectations

The weight loss achieved by Viking Therapeutics’ obesity drug tops results posted by Eli Lilly’s Zepbound in its pivotal test. But Viking still needs to show its results can hold up in a larger Phase 3 clinical trial.

Blackbird Health Secures $17M To Expand Youth Mental Health Model - Vimarsana News

Blackbird Health Secures $17M To Expand Youth Mental Health Model

Blackbird Health's $17 million Series A funding round was led by Define Ventures and included participation from Frist Cressey Ventures and GreyMatter. In total, the startup has raised nearly $23 million.

Dentistry's Technological Revolution Is Transforming Patient Trust - Vimarsana News

Dentistry's Technological Revolution Is Transforming Patient Trust

The way dentistry has embraced technological innovation to make patient care both safer and more comfortable serves as an example for the rest of the healthcare sector.

Lose Fat, Not Muscle: Next Test for Lilly's Zepbound Pairs It With BioAge Drug - Vimarsana News

Lose Fat, Not Muscle: Next Test for Lilly's Zepbound Pairs It With BioAge Drug

In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.